Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GOOSE Capital, previously known as The GOOSE Society of Texas, is a Houston-based angel and early-stage venture investment group rather than a biotech, pharma, or healthcare operating company. The organization was founded in 2005 and has been described as a network of experienced executives, entrepreneurs, and investors that provides capital, mentorship, and board-level support to startup companies. Its focus appears to be broad early-stage venture investing in breakthrough and emerging technologies across multiple sectors, including but not limited to life sciences. Because it is an investor organization and not a therapeutic developer, it does not have a drug pipeline, clinical programs, or proprietary therapeutic modalities in the usual biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GOOSE Capital.